Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes
NCT06934707 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27
Last updated 2025-04-18
Summary
The goal of this clinical trial is to examine the effect of 3 versus 6 daily meals of isocaloric diets on glycemic control and variability in individuals with type 1 diabetes. Participants will be randomized in a crossover clinical trial and will receive two different types of isocaloric diet interventions, in 3 meals/day (calorie distribution: 30% at breakfast, 40% at lunch and 30% at dinner) or 6 meals/day (calorie distribution: 20% at breakfast, 10% at morning snack, 30% at lunch, 10% at afternoon snack, 25% at dinner and 5% at evening snack), for three weeks, with a 4-week washout period between diets.
Conditions
- Type 1 Diabetes (T1D)
- Nutrition Therapy
- Glycemic Control for Diabetes Mellitus
Interventions
- BEHAVIORAL
-
Three meals a day
This group will follow a dietary prescription consisting of three meals per day. The total energy value will be distributed in accordance with the macronutrient recommendations for type 1 diabetes (T1D), as follows: 45% of energy from total carbohydrates, prioritizing those with a low glycemic index; up to 30% from total fats, with unsaturated fats being the primary source; and 25% of energy from proteins. Caloric distribution will be divided into 30% for breakfast, 40% for lunch, and 30% for dinner, with 14 g of fiber per 1000 kcal distributed across the three meals. Furthermore, the gram amounts of the macronutrient in each meal will be apportioned such that 15-20% of the total carbohydrate intake, 7-10% of the total protein intake, and 10% of the total fat intake.Participants will also be instructed to maintain their habitual physical activity level.
- BEHAVIORAL
-
Six meals a day
This group will follow a dietary prescription consisting of six meals per day. The total energy value will be distributed in accordance with the macronutrient recommendations for type 1 diabetes (T1D), as follows: 45% of energy from total carbohydrates, prioritizing those with a low glycemic index; up to 30% from total fats, with unsaturated fats being the primary source; and 25% of energy from proteins. Caloric distribution will be divided into 20% for breakfast, 10% morning snack, 30% for lunch, 10% afternoon snack, 25% for dinner and 5% bedtime snack, with 14 g of fiber per 1000 kcal distributed across the three meals. Furthermore, the gram amounts of the macronutrient in each meal will be apportioned such that 5-10% of the total carbohydrate intake, 2-7% of the total protein intake, and 2-8% of the total fat intake.Participants will also be instructed to maintain their habitual physical activity level.
Sponsors & Collaborators
-
Hospital de Clinicas de Porto Alegre
lead OTHER
Principal Investigators
-
Fernando Gerchman · Hospital de Clínicas de Porto Alegre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-20
- Primary Completion
- 2026-12-29
- Completion
- 2027-12-29
Countries
- Brazil
Study Locations
More Related Trials
-
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
NCT00993720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes
NCT01509742 ·Status: COMPLETED ·Phase: PHASE1
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis
NCT02342834 ·Status: COMPLETED ·Phase: NA
-
Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
NCT07021456 ·Status: RECRUITING
-
Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes
NCT01977833 ·Status: UNKNOWN ·Phase: NA
-
Triple Therapy in T1DM
NCT03899402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Individualised Postprandial Glucose Responses in Type 1 Diabetes
NCT05231642 ·Status: COMPLETED ·Phase: NA
-
The Impact of Time Restricted Eating on Type 2 Diabetes
NCT06887543 ·Status: TERMINATED ·Phase: NA
-
Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy
NCT07151924 ·Status: ACTIVE_NOT_RECRUITING
-
The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
NCT06173934 ·Status: RECRUITING ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia
NCT00418288 ·Status: COMPLETED ·Phase: NA
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
Effect of Breakfast or Omission of Breakfast in T2D
NCT01571310 ·Status: COMPLETED ·Phase: NA
-
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
NCT06976619 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of a Low-Carbohydrate Diet in Pediatric Type 1 Diabetes
NCT03997409 ·Status: COMPLETED ·Phase: NA
-
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
NCT01173978 ·Status: COMPLETED ·Phase: NA
-
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
NCT05297045 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
NCT06503809 ·Status: RECRUITING ·Phase: NA
-
Impact of Dietary Fat and Menstrual Cycle Phases in Type 1 Diabetes
NCT07278063 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Precise Eating Time to Improve Glycemic Control and Cardiometabolic Health in Prediabetes and Diabetes
NCT07171281 ·Status: RECRUITING ·Phase: NA
-
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
NCT07313384 ·Status: RECRUITING
-
GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake
NCT03526289 ·Status: COMPLETED ·Phase: NA